In an effort to potentiate the inhibition of pituitary adenoma cell growth against a background of altered DA resistance and side effects, we evaluated ART in combination with low-dose BRC, and demonstrated that this combination treatment inhibited pituitary adenoma GH3 and MMQ cell growth. This evidence concerns the gene H3-4 and pituitary gland adenoma.